US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

VistaGen Therapeutics

2.11

+0.04001.93%

Post-market: 2.05-0.0600-2.84%19:22 EDT

Volume:70.76K

Turnover:147.50K

Market Cap:60.90M

PE:-1.36

High:2.13

Open:2.07

Low:2.00

Close:2.07

Loading ...

Overview Company News Filings

Vistagen Presents New Research on the Impact of Social Anxiety Disorder at The Anxiety and Depression Association 2025 Conference

Vistagen to Present at the 2025 Anxiety and Depression Association Conference

Vistagen to Participate in Stifel 2025 Virtual CNS Forum

Vistagen Therapeutics Third Quarter 2025 Earnings: Beats Expectations

Simply Wall St.

Vistagen Therapeutics Inc (VTGN) Q3 2025 Earnings Call Highlights: Promising Trial Results and ...

VistaGen Therapeutics, Inc. (VTGN) Reports Q3 Loss, Misses Revenue Estimates

Vistagen Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary

VistaGen Therapeutics Q3 EPS $(0.46) Beats $(0.51) Estimate, Sales $234.00K Beat $180.00K Estimate

Vistagen Reports Fiscal Year 2025 Third Quarter Financial Results and Corporate Update

Vistagen Therapeutics Inc expected to post a loss of 51 cents a share - Earnings Preview

Vistagen Therapeutics Inc expected to post a loss of 51 cents a share - Earnings Preview

Press Release: Vistagen to Report Fiscal Year 2025 Third Quarter Results and Host Corporate Update Conference Call on February 13, 2025

Vistagen granted USPTO patent for AV-101 to treat neuropathic pain

BRIEF-Vistagen Receives U.S. Patent for AV-101 to Treat Neuropathic Pain

Vistagen Receives U.S. Patent for Av-101 to Treat Neuropathic Pain

THOMSON REUTERS

Vistagen Therapeutics Inc - Patent Will Not Expire Until at Least 2034

THOMSON REUTERS

Vistagen Therapeutics-Plans to Seek Potential Strategic Collaborations to Further Advance Potential Clinical Development, Commercialization of Av-101

THOMSON REUTERS

BRIEF-Vistagen Announces Positive Results from Exploratory Phase 2A Study of PH284 in Cancer Cachexia

Vistagen Therapeutics Inc - Phase 2a Study Evaluates Efficacy, Safety, and Tolerability of Ph284

THOMSON REUTERS

Vistagen Announces Positive Results From Exploratory Phase 2a Study of Ph284 in Cancer Cachexia

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VTGN/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VTGN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VTGN\",,,,,undefined,":{"symbol":"VTGN","market":"US","secType":"STK","nameCN":"VistaGen Therapeutics","latestPrice":2.11,"timestamp":1744920000000,"preClose":2.07,"halted":0,"volume":70760,"hourTrading":{"tag":"盘后","latestPrice":2.05,"preClose":2.11,"latestTime":"19:22 EDT","volume":135,"amount":277.01,"timestamp":1744932172896},"delay":0,"floatShares":20224805,"shares":28862085,"eps":-1.54687,"marketStatus":"Closed Good Friday","change":0.04,"latestTime":"04-17 16:00:00 EDT","open":2.07,"high":2.125,"low":2,"amount":147499.29076,"amplitude":0.060386,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.54687,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1462939200000,"exchange":"NASDAQ","adjPreClose":2.07,"postHourTrading":{"tag":"盘后","latestPrice":2.05,"preClose":2.11,"latestTime":"19:22 EDT","volume":135,"amount":277.01,"timestamp":1744932172896},"volumeRatio":0.7532932629713012,"impliedVol":0.0004,"impliedVolPercentile":0.004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VTGN\",,,,,undefined,":{"symbol":"VTGN","floatShares":20224805,"roa":"-29.57%","roe":"-46.28%","lyrEps":-1.517063,"volumeRatio":0.7532932629713012,"shares":28862085,"dividePrice":0,"high":2.125,"amplitude":0.060386,"preClose":2.07,"low":2,"week52Low":1.9,"pbRate":"0.75","psRate":"87.25","week52High":5,"institutionHeld":0,"latestPrice":2.11,"eps":-1.54687,"divideRate":0,"volume":70760,"delay":0,"ttmEps":-1.54687,"open":2.07,"prevYearClose":2.95,"prevWeekClose":2.12,"prevMonthClose":2.5,"prevQuarterClose":2.5,"fiveDayClose":2.05,"twentyDayClose":2.77,"sixtyDayClose":2.99},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VTGN\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528971440","title":"Vistagen Presents New Research on the Impact of Social Anxiety Disorder at The Anxiety and Depression Association 2025 Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2528971440","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528971440?lang=en_us&edition=fundamental","pubTime":"2025-04-17 20:30","pubTimestamp":1744893000,"startTime":"0","endTime":"0","summary":"New Data Build on Recent Epidemiology Findings Presented by the Company at the 2024 Neuroscience Education Institute Congress. The Need for Improved Diagnosis and Treatment Options Underscored by Data Presented in Posters. \"This new research provides a clearer and more comprehensive picture of social anxiety disorder — shining light on its rising prevalence and significant impact on young adults,\" said Ross Baker, Ph.D., MBA, Vice President, Medical Strategy at Vistagen and a co-author of the research. \"Existing therapies remain limited, and these findings reinforce the urgent need for new treatment options. The new research also highlights the critical role of timely diagnosis to improve patient outcomes.\". The key findings from the poster presentations by Vistagen at the ADAA and NEI conferences reveal important insights into SAD, including:","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vistagen-presents-research-impact-social-123000130.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","VTGN"],"gpt_icon":1},{"id":"2520518145","title":"Vistagen to Present at the 2025 Anxiety and Depression Association Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2520518145","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520518145?lang=en_us&edition=fundamental","pubTime":"2025-03-19 20:30","pubTimestamp":1742387400,"startTime":"0","endTime":"0","summary":"Posters Highlight New Insights into Social Anxiety Disorder. SOUTH SAN FRANCISCO, Calif., March 19, 2025----Vistagen , a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced it will present at the Anxiety and Depression Association of America  Conference in Las Vegas, Nevada from April 3 to 5, 2025. The Company’s poster presentations will explore the age of onset of social anxiety disorder  from participants in fasedienol clinical trials, and new data on the characteristics of young adults with and without SAD.Date: Saturday, April 5, 2025, 5:00 p.m. Eastern TimeTitle: Social Anxiety Disorder among Young Adults : A Cross-Sectional Study Using Data from the US National Health and Wellness SurveyAuthors: Ross A. Baker, PhD; Josh Prince; Nikoletta Sternbach; Soohyun Hwang, PhD, MPHPoster Number: S109. This press release contains certain f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vistagen-present-2025-anxiety-depression-123000467.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","VTGN"],"gpt_icon":0},{"id":"2516467905","title":"Vistagen to Participate in Stifel 2025 Virtual CNS Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2516467905","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516467905?lang=en_us&edition=fundamental","pubTime":"2025-03-04 21:30","pubTimestamp":1741095000,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., March 04, 2025----Vistagen , a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced that management will participate in Stifel’s 2025 Virtual CNS Forum.Vistagen’s President and Chief Executive Officer, Shawn Singh, will participate in a fireside chat presentation on Tuesday, March 18, 2025, at 12 p.m. Eastern Time. A live webcast will be accessible through the \"Events\" page in the \"Investors\" section of the Company’s website at www.Vistagen.com. A replay of the webcast will be archived and available following the event.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vistagen-participate-stifel-2025-virtual-133000498.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SF","VTGN","CNS","FET","BK4127","BK4135","BK4139","BK4179"],"gpt_icon":1},{"id":"2511710946","title":"Vistagen Therapeutics Third Quarter 2025 Earnings: Beats Expectations","url":"https://stock-news.laohu8.com/highlight/detail?id=2511710946","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511710946?lang=en_us&edition=fundamental","pubTime":"2025-02-15 20:33","pubTimestamp":1739622823,"startTime":"0","endTime":"0","summary":"NasdaqCM:VTGN Earnings and Revenue History February 15th 2025. All figures shown in the chart above are for the trailing 12 month  period. Revenue exceeded analyst estimates by 31%. Earnings per share  also surpassed analyst estimates by 9.8%.Looking ahead, revenue is forecast to grow 65% p.a. on average during the next 3 years, compared to a 21% growth forecast for the Biotechs industry in the US.The company's shares are up 5.7% from a week ago.You still need to take note of risks, for example - Vistagen Therapeutics has   3 warning signs    we think you should know about.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vistagen-therapeutics-third-quarter-2025-123343743.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","VTGN"],"gpt_icon":0},{"id":"2511809653","title":"Vistagen Therapeutics Inc (VTGN) Q3 2025 Earnings Call Highlights: Promising Trial Results and ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2511809653","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511809653?lang=en_us&edition=fundamental","pubTime":"2025-02-14 15:22","pubTimestamp":1739517748,"startTime":"0","endTime":"0","summary":"For the complete transcript of the earnings call, please refer to the full earnings call transcript.Vistagen Therapeutics Inc  reported positive results from their Palisade 2 Phase 3 trial for the acute treatment of social anxiety disorder  with their lead product candidate, fasinol.The company has initiated Palisade 3 and Palisade 4 Phase 3 trials, which are advancing towards expected top-line results later this year.Vistagen has a strong cash position with $88.6 million in cash equivalents and marketable securities as of December 31, 2024, providing financial stability for ongoing research and development.A: Sean Singh, CEO: There is a robust market in the U.S. with over 30 million adults affected by social anxiety disorder. Our approach is unique, relying on nose-to-brain neu","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vistagen-therapeutics-inc-vtgn-q3-072228859.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VTGN"],"gpt_icon":0},{"id":"2511504178","title":"VistaGen Therapeutics, Inc. (VTGN) Reports Q3 Loss, Misses Revenue Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2511504178","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511504178?lang=en_us&edition=fundamental","pubTime":"2025-02-14 06:55","pubTimestamp":1739487305,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics, Inc.  came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.50. This compares to loss of $0.22 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 8%. A quarter ago, it was expected that this company would post a loss of $0.40 per share when it actually produced a loss of $0.42, delivering a surprise of -5%.VistaGen Therapeutics , which belongs to the Zacks Medical - Biomedical and Genetics industry, posted revenues of $0.23 million for the quarter ended December 2024, missing the Zacks Consensus Estimate by 35%. This compares to year-ago revenues of $0.41 million. The company has not been able to beat consensus revenue estimates over the last four quarters.VistaGen Therapeutics shares have lost about 7.1% since the beginning of the year versus the S&P 500's gain of 2.9%.While VistaGen Therapeutics has underperformed the market so far this","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vistagen-therapeutics-inc-vtgn-reports-225505166.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VTGN"],"gpt_icon":0},{"id":"2511503697","title":"Vistagen Therapeutics Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2511503697","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511503697?lang=en_us&edition=fundamental","pubTime":"2025-02-14 06:02","pubTimestamp":1739484133,"startTime":"0","endTime":"0","summary":"Vistagen Therapeutics Inc reports results for the quarter ended December 31 - Earnings SummaryVistagen Therapeutics Inc VTGN.OQ reported a quarterly adjusted loss of 46 cents per share for the quarter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nL8N3P4316:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN"],"gpt_icon":0},{"id":"2511650866","title":"VistaGen Therapeutics Q3 EPS $(0.46) Beats $(0.51) Estimate, Sales $234.00K Beat $180.00K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2511650866","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511650866?lang=en_us&edition=fundamental","pubTime":"2025-02-14 05:42","pubTimestamp":1739482939,"startTime":"0","endTime":"0","summary":"VistaGen Therapeutics (NASDAQ:VTGN) reported quarterly losses of $(0.46) per share which beat the analyst consensus estimate of $(0.51) by 9.8 percent. This is a 109.09 percent decrease over losses of $(0.22) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/02/43714278/vistagen-therapeutics-q3-eps-0-46-beats-0-51-estimate-sales-234-00k-beat-180-00k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"VistaGen Therapeutics Q3 EPS $(0.46) Beats $(0.51) Estimate, Sales $234.00K Beat $180.00K Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN"],"gpt_icon":1},{"id":"2511081825","title":"Vistagen Reports Fiscal Year 2025 Third Quarter Financial Results and Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2511081825","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511081825?lang=en_us&edition=fundamental","pubTime":"2025-02-14 05:30","pubTimestamp":1739482200,"startTime":"0","endTime":"0","summary":"Fasedienol U.S. registration-directed PALISADE Phase 3 Program for acute treatment of social anxiety disorder progressing with ongoing PALISADE-3, PALISADE-4 and Repeat Dose trials. Vistagen highlights clinical-stage pipeline with five novel pherine product candidates with positive efficacy signals and potential to transform standards of care for multiple high prevalence indications. SOUTH SAN FRANCISCO, Calif., February 13, 2025----Vistagen , a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today reported financial results for its fiscal year 2025 third quarter ended December 31, 2024, and provided a corporate update.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vistagen-reports-fiscal-2025-third-213000688.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VTGN","BK4139"],"gpt_icon":1},{"id":"2510350945","title":"Vistagen Therapeutics Inc  expected to post a loss of 51 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2510350945","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510350945?lang=en_us&edition=fundamental","pubTime":"2025-02-12 05:34","pubTimestamp":1739309646,"startTime":"0","endTime":"0","summary":"Vistagen Therapeutics Inc  expected to post a loss of51cents a share - Earnings Preview Vistagen Therapeutics Inc VTGN.OQ VTGN.O is expected to show a fall in quarterly revenue when it reports  result","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250211:nL8N3P22N8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN"],"gpt_icon":0},{"id":"2509719384","title":"Vistagen Therapeutics Inc  expected to post a loss of 51 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2509719384","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509719384?lang=en_us&edition=fundamental","pubTime":"2025-02-07 19:07","pubTimestamp":1738926428,"startTime":"0","endTime":"0","summary":"Vistagen Therapeutics Inc  expected to post a loss of51cents a share - Earnings Preview Vistagen Therapeutics Inc VTGN.OQ VTGN.O is expected to show a fall in quarterly revenue when it reports  result","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250207:nL8N3OY0Y5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN"],"gpt_icon":0},{"id":"2509276997","title":"Press Release: Vistagen to Report Fiscal Year 2025 Third Quarter Results and Host Corporate Update Conference Call on February 13, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2509276997","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509276997?lang=en_us&edition=fundamental","pubTime":"2025-02-06 21:37","pubTimestamp":1738849020,"startTime":"0","endTime":"0","summary":"Vistagen to Report Fiscal Year 2025 Third Quarter Results and Host Corporate Update Conference Call on February 13, 2025. Vistagen , a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, today announced it will host a conference call and webcast on Thursday, February 13, 2025 at 2:00 p.m. Pacific Time  to report results for its fiscal year 2025 third quarter ended December 31, 2024, and provide a corporate update.The conference call is being webcast live and a link can be found under \"Events\" in the Investors section of the Company's website.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4139","VTGN","BK4588","BK4218","HST","BK4181"],"gpt_icon":0},{"id":"2509289336","title":"Vistagen granted USPTO patent for AV-101 to treat neuropathic pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2509289336","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509289336?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:40","pubTimestamp":1738762826,"startTime":"0","endTime":"0","summary":"Vistagen (VTGN) announced that the U.S. Patent and Trademark Office or USPTO, granted a patent to the company for its oral non-opioid product candi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/vistagen-granted-uspto-patent-for-av-101-to-treat-neuropathic-pain?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/vistagen-granted-uspto-patent-for-av-101-to-treat-neuropathic-pain?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","VTGN"],"gpt_icon":0},{"id":"2509286465","title":"BRIEF-Vistagen Receives U.S. Patent for AV-101 to Treat Neuropathic Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2509286465","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509286465?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:38","pubTimestamp":1738762720,"startTime":"0","endTime":"0","summary":"BRIEF-Vistagen Receives U.S. Patent for AV-101 to Treat Neuropathic PainFeb 5 (Reuters) - VistaGen Therapeutics Inc VTGN.O:VISTAGEN RECEIVES U.S. PATENT FOR AV-101 TO TREAT NEUROPATHIC PAINVISTAGEN TH","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nFWN3OW0YL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"gpt_icon":1},{"id":"2509863952","title":"Vistagen Receives U.S. Patent for Av-101 to Treat Neuropathic Pain","url":"https://stock-news.laohu8.com/highlight/detail?id=2509863952","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509863952?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:30","pubTimestamp":1738762244,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nFWN3OW0YL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VTGN"],"gpt_icon":0},{"id":"2509378286","title":"Vistagen Therapeutics Inc - Patent Will Not Expire Until at Least 2034","url":"https://stock-news.laohu8.com/highlight/detail?id=2509378286","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509378286?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:30","pubTimestamp":1738762244,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nFWN3OW0YL:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2509286392","title":"Vistagen Therapeutics-Plans to Seek Potential Strategic Collaborations to Further Advance Potential Clinical Development, Commercialization of Av-101","url":"https://stock-news.laohu8.com/highlight/detail?id=2509286392","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509286392?lang=en_us&edition=fundamental","pubTime":"2025-02-05 21:30","pubTimestamp":1738762244,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250205:nFWN3OW0YL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VTGN"],"gpt_icon":0},{"id":"2503578410","title":"BRIEF-Vistagen Announces Positive Results from Exploratory Phase 2A Study of PH284 in Cancer Cachexia","url":"https://stock-news.laohu8.com/highlight/detail?id=2503578410","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503578410?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:32","pubTimestamp":1736861522,"startTime":"0","endTime":"0","summary":"Jan 14  - VistaGen Therapeutics Inc   :   * VISTAGEN ANNOUNCES POSITIVE RESULTS FROM EXPLORATORY PHASE 2A STUDY OF PH284 IN CANCER CACHEXIA   * VISTAGEN ANNOUNCES POSITIVE RESULTS FROM EXPLORATORY PHASE 2A STUDY OF PH284 IN CANCER CACHEXIA   * VISTAGEN THERAPEUTICS INC - PH284 DEMONSTRATES NO SERIOUS ADVERSE EVENTS   * VISTAGEN THERAPEUTICS INC - PHASE 2A STUDY EVALUATES EFFICACY, SAFETY, AND TOLERABILITY OF PH284Source text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"BRIEF-Vistagen Announces Positive Results from Exploratory Phase 2A Study of PH284 in Cancer Cachexia","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTGN","BK4139"],"gpt_icon":1},{"id":"2503781785","title":"Vistagen Therapeutics Inc - Phase 2a Study Evaluates Efficacy, Safety, and Tolerability of Ph284","url":"https://stock-news.laohu8.com/highlight/detail?id=2503781785","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503781785?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:30","pubTimestamp":1736861401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nTUABSD0MC:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VTGN","BK4139"],"gpt_icon":0},{"id":"2503781225","title":"Vistagen Announces Positive Results From Exploratory Phase 2a Study of Ph284 in Cancer Cachexia","url":"https://stock-news.laohu8.com/highlight/detail?id=2503781225","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503781225?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:30","pubTimestamp":1736861401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250114:nTUABSD0MC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","VTGN"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VTGN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-13","symbol":"VTGN","fiscalQuarterEnding":"2024/12","expectedEps":-0.5,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739422800000,"reportTimeType":"post","actualEps":-0.46},{"market":"US","date":"2024-11-07","symbol":"VTGN","fiscalQuarterEnding":"2024/09","expectedEps":-0.4,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.42},{"market":"US","date":"2024-08-13","symbol":"VTGN","fiscalQuarterEnding":"2024/06","expectedEps":-0.41,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-0.35},{"market":"US","date":"2024-06-11","symbol":"VTGN","fiscalQuarterEnding":"2024/03","expectedEps":-0.34,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1718078400000,"reportTimeType":"post","actualEps":-0.25},{"market":"US","date":"2024-02-13","symbol":"VTGN","fiscalQuarterEnding":"2023/12","expectedEps":-0.31,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1707800400000,"reportTimeType":"post","actualEps":-0.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VTGN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VTGN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.75,"buy":0.25,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.75,"analysts":4,"updateTime":1701921600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VTGN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VTGN","date":"2025-04-17","current":-1.262991,"percent":0.722764,"low":-37.785134,"twenty":-11.839382,"median":-2.927982,"eighty":-0.739388,"high":-0.195082,"avg":-6.961916,"sd":9.183434,"marketCap":59744515},"quantilePoints":[{"date":"2020-04-24","current":-0.843146,"twenty":-2.253799,"median":-1.597523,"eighty":-0.742724,"marketCap":19586790},{"date":"2020-05-01","current":-0.863641,"twenty":-2.248215,"median":-1.581358,"eighty":-0.742724,"marketCap":20062907},{"date":"2020-05-08","current":-0.895628,"twenty":-2.239258,"median":-1.551696,"eighty":-0.742724,"marketCap":20805977},{"date":"2020-05-15","current":-0.859867,"twenty":-2.230261,"median":-1.549627,"eighty":-0.742724,"marketCap":19975216},{"date":"2020-05-22","current":-1.006044,"twenty":-2.216842,"median":-1.529213,"eighty":-0.742724,"marketCap":23371003},{"date":"2020-05-29","current":-0.949293,"twenty":-2.21315,"median":-1.515311,"eighty":-0.742724,"marketCap":22052639},{"date":"2020-06-05","current":-0.994436,"twenty":-2.200869,"median":-1.481911,"eighty":-0.742724,"marketCap":23101338},{"date":"2020-06-12","current":-1.155231,"twenty":-2.195619,"median":-1.473691,"eighty":-0.742724,"marketCap":26836703},{"date":"2020-06-19","current":-1.101489,"twenty":-2.184898,"median":-1.463217,"eighty":-0.742724,"marketCap":25588252},{"date":"2020-06-26","current":-1.115892,"twenty":-2.179626,"median":-1.44825,"eighty":-0.742724,"marketCap":25922837},{"date":"2020-07-02","current":-1.42562,"twenty":-2.173272,"median":-1.445801,"eighty":-0.742724,"marketCap":29615825},{"date":"2020-07-10","current":-1.297287,"twenty":-2.167921,"median":-1.438446,"eighty":-0.742724,"marketCap":26949843},{"date":"2020-07-17","current":-1.570598,"twenty":-2.154905,"median":-1.438446,"eighty":-0.742724,"marketCap":32627603},{"date":"2020-07-24","current":-2.05359,"twenty":-2.144456,"median":-1.438446,"eighty":-0.742724,"marketCap":42661289},{"date":"2020-07-31","current":-2.514134,"twenty":-2.144456,"median":-1.438446,"eighty":-0.742724,"marketCap":52228620},{"date":"2020-08-07","current":-3.089651,"twenty":-2.144456,"median":-1.438446,"eighty":-0.742724,"marketCap":64184406},{"date":"2020-08-14","current":-3.162221,"twenty":-2.144456,"median":-1.438446,"eighty":-0.742724,"marketCap":55942531},{"date":"2020-08-21","current":-2.87737,"twenty":-2.145804,"median":-1.438446,"eighty":-0.742724,"marketCap":50903263},{"date":"2020-08-28","current":-2.887409,"twenty":-2.152145,"median":-1.438446,"eighty":-0.742724,"marketCap":51080858},{"date":"2020-09-04","current":-2.541907,"twenty":-2.160117,"median":-1.438446,"eighty":-0.742724,"marketCap":44968619},{"date":"2020-09-11","current":-2.562821,"twenty":-2.168669,"median":-1.438446,"eighty":-0.742724,"marketCap":45338609},{"date":"2020-09-18","current":-2.695417,"twenty":-2.17444,"median":-1.438446,"eighty":-0.742724,"marketCap":47684347},{"date":"2020-09-25","current":-2.57286,"twenty":-2.180777,"median":-1.438446,"eighty":-0.742724,"marketCap":45516204},{"date":"2020-10-02","current":-3.061833,"twenty":-2.188503,"median":-1.438446,"eighty":-0.742724,"marketCap":54166577},{"date":"2020-10-09","current":-3.11621,"twenty":-2.200038,"median":-1.438446,"eighty":-0.742724,"marketCap":55128552},{"date":"2020-10-16","current":-3.413609,"twenty":-2.205567,"median":-1.438446,"eighty":-0.742724,"marketCap":60389814},{"date":"2020-10-23","current":-3.281431,"twenty":-2.216002,"median":-1.438446,"eighty":-0.742724,"marketCap":58051475},{"date":"2020-10-30","current":-2.992398,"twenty":-2.228727,"median":-1.438446,"eighty":-0.742724,"marketCap":52938209},{"date":"2020-11-06","current":-2.823411,"twenty":-2.235372,"median":-1.440595,"eighty":-0.742724,"marketCap":49948688},{"date":"2020-11-13","current":-3.309225,"twenty":-2.243769,"median":-1.447362,"eighty":-0.742724,"marketCap":51798639},{"date":"2020-11-20","current":-3.358391,"twenty":-2.251548,"median":-1.461665,"eighty":-0.742724,"marketCap":52568219},{"date":"2020-11-27","current":-3.640148,"twenty":-2.258433,"median":-1.467237,"eighty":-0.742724,"marketCap":56978503},{"date":"2020-12-04","current":-3.630693,"twenty":-2.266793,"median":-1.47671,"eighty":-0.742724,"marketCap":56830507},{"date":"2020-12-11","current":-3.474686,"twenty":-2.279445,"median":-1.498443,"eighty":-0.742724,"marketCap":54388571},{"date":"2020-12-18","current":-11.903133,"twenty":-2.291259,"median":-1.520919,"eighty":-0.742724,"marketCap":186317357},{"date":"2020-12-24","current":-12.212852,"twenty":-2.309867,"median":-1.543115,"eighty":-0.742724,"marketCap":191165325},{"date":"2020-12-31","current":-17.084132,"twenty":-2.322388,"median":-1.548046,"eighty":-0.742724,"marketCap":267414498},{"date":"2021-01-08","current":-19.10957,"twenty":-2.333493,"median":-1.548046,"eighty":-0.742724,"marketCap":299118279},{"date":"2021-01-15","current":-21.221638,"twenty":-2.351108,"median":-1.548046,"eighty":-0.742724,"marketCap":332178060},{"date":"2021-01-22","current":-19.541592,"twenty":-2.35963,"median":-1.548046,"eighty":-0.742724,"marketCap":305880630},{"date":"2021-01-29","current":-18.74578,"twenty":-2.377597,"median":-1.548046,"eighty":-0.742724,"marketCap":293423953},{"date":"2021-02-05","current":-17.949969,"twenty":-2.395255,"median":-1.548046,"eighty":-0.742724,"marketCap":280967275},{"date":"2021-02-12","current":-18.054458,"twenty":-2.424455,"median":-1.548046,"eighty":-0.742724,"marketCap":270636328},{"date":"2021-02-19","current":-27.979684,"twenty":-2.444135,"median":-1.559823,"eighty":-0.742724,"marketCap":419415462},{"date":"2021-02-26","current":-23.347912,"twenty":-2.449711,"median":-1.559823,"eighty":-0.742724,"marketCap":349985200},{"date":"2021-03-05","current":-20.134029,"twenty":-2.470472,"median":-1.558206,"eighty":-0.742674,"marketCap":301809099},{"date":"2021-03-12","current":-22.2136,"twenty":-2.499151,"median":-1.561745,"eighty":-0.742674,"marketCap":332981870},{"date":"2021-03-19","current":-22.471645,"twenty":-2.519736,"median":-1.561745,"eighty":-0.742674,"marketCap":336849963},{"date":"2021-03-26","current":-20.559165,"twenty":-2.555481,"median":-1.563666,"eighty":-0.742724,"marketCap":308181881},{"date":"2021-04-01","current":-20.941661,"twenty":-2.570852,"median":-1.563666,"eighty":-0.742724,"marketCap":313915497},{"date":"2021-04-09","current":-20.654789,"twenty":-2.606601,"median":-1.561745,"eighty":-0.742674,"marketCap":309615285},{"date":"2021-04-16","current":-19.602925,"twenty":-2.636028,"median":-1.561745,"eighty":-0.742674,"marketCap":293847840},{"date":"2021-04-23","current":-19.507301,"twenty":-2.644829,"median":-1.561745,"eighty":-0.742674,"marketCap":292414436},{"date":"2021-04-30","current":-32.079325,"twenty":-2.679147,"median":-1.561745,"eighty":-0.742674,"marketCap":480869082},{"date":"2021-05-07","current":-32.586508,"twenty":-2.685764,"median":-1.561745,"eighty":-0.742674,"marketCap":488471755},{"date":"2021-05-14","current":-27.134291,"twenty":-2.72478,"median":-1.583089,"eighty":-0.742674,"marketCap":406743018},{"date":"2021-05-21","current":-35.756402,"twenty":-2.752079,"median":-1.598123,"eighty":-0.742674,"marketCap":535988463},{"date":"2021-05-28","current":-32.8401,"twenty":-2.768658,"median":-1.630931,"eighty":-0.742674,"marketCap":492273092},{"date":"2021-06-04","current":-30.557776,"twenty":-2.77947,"median":-1.651439,"eighty":-0.742674,"marketCap":458061062},{"date":"2021-06-11","current":-35.50281,"twenty":-2.792773,"median":-1.67478,"eighty":-0.742674,"marketCap":532187126},{"date":"2021-06-18","current":-36.643972,"twenty":-2.812661,"median":-1.694545,"eighty":-0.742674,"marketCap":549293141},{"date":"2021-06-25","current":-33.600874,"twenty":-2.818394,"median":-1.70616,"eighty":-0.742823,"marketCap":503677102},{"date":"2021-07-02","current":-36.175919,"twenty":-2.835565,"median":-1.70616,"eighty":-0.742823,"marketCap":648786166},{"date":"2021-07-09","current":-33.081224,"twenty":-2.85862,"median":-1.70616,"eighty":-0.742823,"marketCap":593285285},{"date":"2021-07-16","current":-29.239533,"twenty":-2.885827,"median":-1.70616,"eighty":-0.742823,"marketCap":524387639},{"date":"2021-07-23","current":-30.62681,"twenty":-2.916894,"median":-1.70616,"eighty":-0.742823,"marketCap":549267344},{"date":"2021-07-30","current":-28.492113,"twenty":-2.924134,"median":-1.70616,"eighty":-0.742823,"marketCap":510983246},{"date":"2021-08-06","current":-29.777471,"twenty":-2.938849,"median":-1.715533,"eighty":-0.742823,"marketCap":534035122},{"date":"2021-08-13","current":-23.693959,"twenty":-2.968928,"median":-1.732484,"eighty":-0.743545,"marketCap":534343791},{"date":"2021-08-20","current":-23.009657,"twenty":-3.016018,"median":-1.747566,"eighty":-0.760103,"marketCap":518911480},{"date":"2021-08-27","current":-26.089016,"twenty":-3.058487,"median":-1.763279,"eighty":-0.772114,"marketCap":588356882},{"date":"2021-09-03","current":-27.029931,"twenty":-3.093037,"median":-1.773644,"eighty":-0.779499,"marketCap":609576311},{"date":"2021-09-10","current":-25.832403,"twenty":-3.133777,"median":-1.781251,"eighty":-0.779499,"marketCap":582569765},{"date":"2021-09-17","current":-25.490252,"twenty":-3.173766,"median":-1.800291,"eighty":-0.779499,"marketCap":574853610},{"date":"2021-09-24","current":-24.207185,"twenty":-3.204832,"median":-1.822788,"eighty":-0.779499,"marketCap":545918025},{"date":"2021-10-01","current":-23.009657,"twenty":-3.282133,"median":-1.835745,"eighty":-0.779499,"marketCap":518911480},{"date":"2021-10-08","current":-21.555515,"twenty":-3.313145,"median":-1.858529,"eighty":-0.779499,"marketCap":486117817},{"date":"2021-10-15","current":-20.443524,"twenty":-3.350636,"median":-1.873762,"eighty":-0.779499,"marketCap":461040311},{"date":"2021-10-22","current":-19.759222,"twenty":-3.375442,"median":-1.904318,"eighty":-0.779499,"marketCap":445607999},{"date":"2021-10-29","current":-19.588146,"twenty":-3.418203,"median":-1.917993,"eighty":-0.779499,"marketCap":441749921},{"date":"2021-11-05","current":-21.127826,"twenty":-3.45338,"median":-1.936117,"eighty":-0.779578,"marketCap":476472623},{"date":"2021-11-12","current":-13.833383,"twenty":-3.484535,"median":-1.960234,"eighty":-0.80279,"marketCap":443339179},{"date":"2021-11-19","current":-13.646446,"twenty":-3.554592,"median":-1.974573,"eighty":-0.825259,"marketCap":437348109},{"date":"2021-11-26","current":-12.150945,"twenty":-3.639335,"median":-1.987522,"eighty":-0.828653,"marketCap":389419549},{"date":"2021-12-03","current":-10.406194,"twenty":-3.687422,"median":-2.014852,"eighty":-0.83885,"marketCap":333502896},{"date":"2021-12-10","current":-11.465507,"twenty":-3.752188,"median":-2.030447,"eighty":-0.842198,"marketCap":367452292},{"date":"2021-12-17","current":-11.777069,"twenty":-7.994202,"median":-2.037895,"eighty":-0.845526,"marketCap":377437409},{"date":"2021-12-23","current":-12.649445,"twenty":-11.091631,"median":-2.047717,"eighty":-0.849351,"marketCap":405395735},{"date":"2021-12-31","current":-12.150945,"twenty":-11.492175,"median":-2.058463,"eighty":-0.853568,"marketCap":389419549},{"date":"2022-01-07","current":-10.967006,"twenty":-11.590132,"median":-2.071065,"eighty":-0.859381,"marketCap":351476106},{"date":"2022-01-14","current":-10.842381,"twenty":-11.590132,"median":-2.072974,"eighty":-0.867858,"marketCap":347482059},{"date":"2022-01-21","current":-9.34688,"twenty":-11.590132,"median":-2.080397,"eighty":-0.869049,"marketCap":299553499},{"date":"2022-01-28","current":-9.596131,"twenty":-11.590132,"median":-2.089644,"eighty":-0.874837,"marketCap":307541592},{"date":"2022-02-04","current":-9.34688,"twenty":-11.590132,"median":-2.097879,"eighty":-0.880305,"marketCap":299553499},{"date":"2022-02-11","current":-8.308777,"twenty":-11.590132,"median":-2.106527,"eighty":-0.889608,"marketCap":309791932},{"date":"2022-02-18","current":-7.699467,"twenty":-11.590132,"median":-2.119816,"eighty":-0.895159,"marketCap":287073857},{"date":"2022-02-25","current":-7.754859,"twenty":-11.590132,"median":-2.123135,"eighty":-0.900425,"marketCap":289139137},{"date":"2022-03-04","current":-6.813197,"twenty":-11.590132,"median":-2.131195,"eighty":-0.912803,"marketCap":254029384},{"date":"2022-03-11","current":-6.59163,"twenty":-11.590132,"median":-2.138746,"eighty":-0.928191,"marketCap":245768266},{"date":"2022-03-18","current":-6.813197,"twenty":-11.590132,"median":-2.144456,"eighty":-0.948857,"marketCap":254029384},{"date":"2022-03-25","current":-6.536238,"twenty":-11.590132,"median":-2.154957,"eighty":-0.957849,"marketCap":243702986},{"date":"2022-04-01","current":-6.370063,"twenty":-11.590132,"median":-2.169872,"eighty":-0.963752,"marketCap":237507148},{"date":"2022-04-08","current":-7.533291,"twenty":-11.590132,"median":-2.178195,"eighty":-0.973722,"marketCap":280878018},{"date":"2022-04-14","current":-8.97348,"twenty":-11.590132,"median":-2.185127,"eighty":-0.983853,"marketCap":334575287},{"date":"2022-04-22","current":-7.699467,"twenty":-11.590132,"median":-2.196891,"eighty":-0.995258,"marketCap":287073857},{"date":"2022-04-29","current":-7.034765,"twenty":-11.590132,"median":-2.203547,"eighty":-1.006149,"marketCap":262290502},{"date":"2022-05-06","current":-7.034765,"twenty":-11.590132,"median":-2.215938,"eighty":-1.021031,"marketCap":262290502},{"date":"2022-05-13","current":-6.314671,"twenty":-11.590132,"median":-2.22671,"eighty":-1.027995,"marketCap":235441868},{"date":"2022-05-20","current":-5.816144,"twenty":-11.590132,"median":-2.236341,"eighty":-1.039985,"marketCap":216854352},{"date":"2022-05-27","current":-5.871536,"twenty":-11.590132,"median":-2.249837,"eighty":-1.053264,"marketCap":218919632},{"date":"2022-06-03","current":-6.370063,"twenty":-11.590132,"median":-2.25698,"eighty":-1.079422,"marketCap":237507148},{"date":"2022-06-10","current":-5.539185,"twenty":-11.590132,"median":-2.268657,"eighty":-1.093745,"marketCap":206527955},{"date":"2022-06-17","current":-5.475484,"twenty":-11.590132,"median":-2.28141,"eighty":-1.100513,"marketCap":204152883},{"date":"2022-06-24","current":-4.256347,"twenty":-11.590132,"median":-2.296391,"eighty":-1.115309,"marketCap":203293371},{"date":"2022-07-01","current":-3.773085,"twenty":-11.590132,"median":-2.321872,"eighty":-1.145312,"marketCap":180211576},{"date":"2022-07-08","current":-4.027479,"twenty":-11.590132,"median":-2.324352,"eighty":-1.154027,"marketCap":192362065},{"date":"2022-07-15","current":-3.375053,"twenty":-11.590132,"median":-2.341195,"eighty":-1.170145,"marketCap":161200608},{"date":"2022-07-22","current":-0.648533,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":30975479},{"date":"2022-07-29","current":-0.619113,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":29570320},{"date":"2022-08-05","current":-0.670165,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":32008683},{"date":"2022-08-12","current":-0.544468,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":32556040},{"date":"2022-08-19","current":-0.743715,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":44469814},{"date":"2022-08-26","current":-0.656198,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":39236854},{"date":"2022-09-02","current":-0.606387,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":36258411},{"date":"2022-09-09","current":-0.715004,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":42753072},{"date":"2022-09-16","current":-0.660695,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":39505741},{"date":"2022-09-23","current":-0.56038,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":33507487},{"date":"2022-09-30","current":-0.526135,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":31459808},{"date":"2022-10-07","current":-0.490506,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":29329393},{"date":"2022-10-14","current":-0.38604,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":23082936},{"date":"2022-10-21","current":-0.366323,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":21903968},{"date":"2022-10-28","current":-0.449689,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":26888802},{"date":"2022-11-04","current":-0.428934,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":25647781},{"date":"2022-11-11","current":-0.519633,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":33507487},{"date":"2022-11-18","current":-0.47633,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":30715197},{"date":"2022-11-25","current":-0.389404,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":25109932},{"date":"2022-12-02","current":-0.434631,"twenty":-11.590132,"median":-2.359022,"eighty":-1.181782,"marketCap":28026324},{"date":"2022-12-09","current":-0.37529,"twenty":-11.590132,"median":-2.359022,"eighty":-1.172623,"marketCap":24199852},{"date":"2022-12-16","current":-0.471519,"twenty":-11.590132,"median":-2.359022,"eighty":-1.16627,"marketCap":30404942},{"date":"2022-12-23","current":-0.313384,"twenty":-11.590132,"median":-2.359022,"eighty":-1.150476,"marketCap":20207910},{"date":"2022-12-30","current":-0.330384,"twenty":-11.590132,"median":-2.359022,"eighty":-1.132526,"marketCap":21304143},{"date":"2023-01-06","current":-0.521557,"twenty":-11.590132,"median":-2.359022,"eighty":-1.111492,"marketCap":33631589},{"date":"2023-01-13","current":-0.513218,"twenty":-11.590132,"median":-2.359022,"eighty":-1.099507,"marketCap":33093815},{"date":"2023-01-20","current":-0.549143,"twenty":-11.590132,"median":-2.359022,"eighty":-1.093055,"marketCap":35410382},{"date":"2023-01-27","current":-0.679693,"twenty":-11.590132,"median":-2.341195,"eighty":-1.07824,"marketCap":43828621},{"date":"2023-02-03","current":-0.962283,"twenty":-11.590132,"median":-2.341031,"eighty":-1.04899,"marketCap":62050903},{"date":"2023-02-10","current":-0.620017,"twenty":-11.590132,"median":-2.341031,"eighty":-1.039212,"marketCap":39500707},{"date":"2023-02-17","current":-0.677853,"twenty":-11.590132,"median":-2.341031,"eighty":-1.026755,"marketCap":43185392},{"date":"2023-02-24","current":-0.614509,"twenty":-11.590132,"median":-2.341031,"eighty":-1.020438,"marketCap":39149784},{"date":"2023-03-03","current":-0.584213,"twenty":-11.590132,"median":-2.341031,"eighty":-1.006123,"marketCap":37219711},{"date":"2023-03-10","current":-0.461656,"twenty":-11.590132,"median":-2.324352,"eighty":-0.995052,"marketCap":29411687},{"date":"2023-03-17","current":-0.475426,"twenty":-11.590132,"median":-2.324352,"eighty":-0.983843,"marketCap":30288982},{"date":"2023-03-24","current":-0.47818,"twenty":-11.590132,"median":-2.324352,"eighty":-0.969566,"marketCap":30464443},{"date":"2023-03-31","current":-0.429295,"twenty":-11.590132,"median":-2.323112,"eighty":-0.962219,"marketCap":27350007},{"date":"2023-04-06","current":-0.456836,"twenty":-11.590132,"median":-2.323112,"eighty":-0.957849,"marketCap":29104619},{"date":"2023-04-14","current":-0.479902,"twenty":-11.590132,"median":-2.324352,"eighty":-0.948422,"marketCap":30574106},{"date":"2023-04-21","current":-0.486098,"twenty":-11.590132,"median":-2.324352,"eighty":-0.920451,"marketCap":30968894},{"date":"2023-04-28","current":-0.470607,"twenty":-11.590132,"median":-2.324352,"eighty":-0.896953,"marketCap":29981925},{"date":"2023-05-05","current":-0.432394,"twenty":-11.590132,"median":-2.324352,"eighty":-0.887332,"marketCap":27547401},{"date":"2023-05-12","current":-0.493328,"twenty":-11.590132,"median":-2.324352,"eighty":-0.868084,"marketCap":31429479},{"date":"2023-05-19","current":-0.48782,"twenty":-11.590132,"median":-2.324352,"eighty":-0.858687,"marketCap":31078557},{"date":"2023-05-26","current":-0.454771,"twenty":-11.590132,"median":-2.321872,"eighty":-0.847383,"marketCap":28973023},{"date":"2023-06-02","current":-0.486098,"twenty":-11.590132,"median":-2.296391,"eighty":-0.842823,"marketCap":30968894},{"date":"2023-06-09","current":-0.290328,"twenty":-11.590132,"median":-2.281329,"eighty":-0.831263,"marketCap":18496511},{"date":"2023-06-16","current":-0.238688,"twenty":-11.590132,"median":-2.262443,"eighty":-0.82638,"marketCap":15206617},{"date":"2023-06-23","current":-0.200819,"twenty":-11.590132,"median":-2.248215,"eighty":-0.803176,"marketCap":12794029},{"date":"2023-06-30","current":-0.239173,"twenty":-11.590132,"median":-2.248215,"eighty":-0.790862,"marketCap":14170462},{"date":"2023-07-07","current":-0.265748,"twenty":-11.590132,"median":-2.239504,"eighty":-0.779697,"marketCap":15744958},{"date":"2023-07-14","current":-0.239173,"twenty":-11.590132,"median":-2.233935,"eighty":-0.766212,"marketCap":14170462},{"date":"2023-07-21","current":-0.248474,"twenty":-11.590132,"median":-2.228997,"eighty":-0.754142,"marketCap":14721535},{"date":"2023-07-28","current":-0.223228,"twenty":-11.590132,"median":-2.228997,"eighty":-0.724814,"marketCap":13225764},{"date":"2023-08-04","current":-0.229111,"twenty":-11.590132,"median":-2.228997,"eighty":-0.710284,"marketCap":13574287},{"date":"2023-08-11","current":-1.293951,"twenty":-11.590132,"median":-2.228997,"eighty":-0.708289,"marketCap":60006335},{"date":"2023-08-18","current":-1.117918,"twenty":-11.590132,"median":-2.228997,"eighty":-0.708289,"marketCap":51842887},{"date":"2023-08-25","current":-1.121954,"twenty":-11.590132,"median":-2.228997,"eighty":-0.708289,"marketCap":52030046},{"date":"2023-09-01","current":-1.075542,"twenty":-11.590132,"median":-2.20645,"eighty":-0.708289,"marketCap":49877724},{"date":"2023-09-08","current":-1.32778,"twenty":-11.590132,"median":-2.204979,"eighty":-0.708289,"marketCap":61575126},{"date":"2023-09-15","current":-1.24101,"twenty":-11.590132,"median":-2.191847,"eighty":-0.708289,"marketCap":57551220},{"date":"2023-09-22","current":-1.03922,"twenty":-11.590132,"median":-2.171822,"eighty":-0.708289,"marketCap":48193298},{"date":"2023-09-29","current":-1.045273,"twenty":-11.590132,"median":-2.122085,"eighty":-0.708289,"marketCap":48474035},{"date":"2023-10-06","current":-1.636861,"twenty":-11.590132,"median":-2.080397,"eighty":-0.708289,"marketCap":75908600},{"date":"2023-10-13","current":-1.760348,"twenty":-11.590132,"median":-2.052187,"eighty":-0.708289,"marketCap":81635252},{"date":"2023-10-20","current":-1.581686,"twenty":-11.590132,"median":-2.0251,"eighty":-0.708289,"marketCap":73349883},{"date":"2023-10-23","current":-1.565921,"twenty":-11.590132,"median":-2.024672,"eighty":-0.708289,"marketCap":72618821},{"date":"2023-11-03","current":-1.723564,"twenty":-11.590132,"median":-1.987522,"eighty":-0.702187,"marketCap":79929440},{"date":"2023-11-10","current":-1.684041,"twenty":-11.590132,"median":-1.950372,"eighty":-0.702187,"marketCap":78096579},{"date":"2023-11-17","current":-2.528721,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":89716486},{"date":"2023-11-24","current":-2.73437,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":97012706},{"date":"2023-12-01","current":-2.73437,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":97012706},{"date":"2023-12-08","current":-3.709298,"twenty":-11.590132,"median":-1.943002,"eighty":-0.703713,"marketCap":131602195},{"date":"2023-12-15","current":-3.777848,"twenty":-11.590132,"median":-1.943002,"eighty":-0.703713,"marketCap":134034268},{"date":"2023-12-22","current":-3.884481,"twenty":-11.590132,"median":-1.943002,"eighty":-0.703713,"marketCap":137817493},{"date":"2023-12-29","current":-3.991114,"twenty":-11.590132,"median":-1.94174,"eighty":-0.702187,"marketCap":141600719},{"date":"2024-01-05","current":-3.876864,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":137547263},{"date":"2024-01-12","current":-4.151063,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":147275557},{"date":"2024-01-19","current":-3.655982,"twenty":-11.590132,"median":-1.925948,"eighty":-0.698735,"marketCap":129710582},{"date":"2024-01-26","current":-3.671215,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":130251043},{"date":"2024-02-02","current":-3.655982,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":129710582},{"date":"2024-02-09","current":-3.770231,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":133764038},{"date":"2024-02-16","current":-4.567745,"twenty":-11.590132,"median":-1.933844,"eighty":-0.700461,"marketCap":146476632},{"date":"2024-02-23","current":-4.146367,"twenty":-11.590132,"median":-1.962469,"eighty":-0.700461,"marketCap":132964028},{"date":"2024-03-01","current":-4.306491,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":138098817},{"date":"2024-03-08","current":-3.569078,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":114451760},{"date":"2024-03-15","current":-3.303609,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":105938819},{"date":"2024-03-22","current":-3.552223,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":113911255},{"date":"2024-03-28","current":-3.851402,"twenty":-11.590132,"median":-1.98137,"eighty":-0.702187,"marketCap":123505205},{"date":"2024-04-05","current":-4.458187,"twenty":-11.590132,"median":-1.975159,"eighty":-0.700461,"marketCap":142963355},{"date":"2024-04-12","current":-4.470828,"twenty":-11.590132,"median":-1.975159,"eighty":-0.700461,"marketCap":143368733},{"date":"2024-04-19","current":-3.96096,"twenty":-11.590132,"median":-1.975159,"eighty":-0.700461,"marketCap":127018482},{"date":"2024-04-26","current":-3.96096,"twenty":-11.590132,"median":-1.987522,"eighty":-0.702187,"marketCap":127018482},{"date":"2024-05-03","current":-3.71656,"twenty":-11.590132,"median":-2.022834,"eighty":-0.702187,"marketCap":119181171},{"date":"2024-05-10","current":-3.775553,"twenty":-11.590132,"median":-2.06822,"eighty":-0.702187,"marketCap":121072936},{"date":"2024-05-17","current":-3.834546,"twenty":-11.590132,"median":-2.260612,"eighty":-0.702187,"marketCap":122964700},{"date":"2024-05-24","current":-3.455306,"twenty":-11.590132,"median":-2.481343,"eighty":-0.702187,"marketCap":110803356},{"date":"2024-05-31","current":-3.278327,"twenty":-11.590132,"median":-2.528721,"eighty":-0.702187,"marketCap":105128063},{"date":"2024-06-07","current":-3.253044,"twenty":-11.590132,"median":-2.569513,"eighty":-0.702187,"marketCap":104317306},{"date":"2024-06-14","current":-3.239859,"twenty":-11.590132,"median":-2.650451,"eighty":-0.700461,"marketCap":95128735},{"date":"2024-06-21","current":-2.963734,"twenty":-11.590132,"median":-2.695417,"eighty":-0.698735,"marketCap":87021172},{"date":"2024-06-28","current":-3.203042,"twenty":-11.590132,"median":-2.73437,"eighty":-0.693557,"marketCap":94047727},{"date":"2024-07-05","current":-3.046572,"twenty":-11.590132,"median":-2.762551,"eighty":-0.693557,"marketCap":89453441},{"date":"2024-07-12","current":-3.59882,"twenty":-11.590132,"median":-2.788793,"eighty":-0.693557,"marketCap":105668567},{"date":"2024-07-15","current":-3.534391,"twenty":-11.590132,"median":-2.795067,"eighty":-0.693557,"marketCap":103776802},{"date":"2024-08-02","current":-3.100103,"twenty":-11.814457,"median":-2.833386,"eighty":-0.682688,"marketCap":91025218},{"date":"2024-08-09","current":-3.14156,"twenty":-11.814457,"median":-2.87737,"eighty":-0.682688,"marketCap":92242494},{"date":"2024-08-16","current":-2.755069,"twenty":-11.814457,"median":-2.894519,"eighty":-0.682688,"marketCap":91446261},{"date":"2024-08-23","current":-2.975149,"twenty":-11.814457,"median":-2.918362,"eighty":-0.682688,"marketCap":98751140},{"date":"2024-08-30","current":-2.869185,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":95233976},{"date":"2024-09-06","current":-2.657256,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":88199648},{"date":"2024-09-13","current":-2.600199,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":86305791},{"date":"2024-09-20","current":-2.445328,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81165321},{"date":"2024-09-27","current":-2.445328,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81165321},{"date":"2024-10-04","current":-2.404572,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":79812565},{"date":"2024-10-11","current":-2.46163,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81706423},{"date":"2024-10-18","current":-2.494234,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":82788627},{"date":"2024-10-25","current":-2.469781,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":81976974},{"date":"2024-10-31","current":-2.518688,"twenty":-11.814457,"median":-2.927982,"eighty":-0.682688,"marketCap":83600280},{"date":"2024-11-08","current":-2.543141,"twenty":-11.826919,"median":-2.927982,"eighty":-0.68268,"marketCap":84411933},{"date":"2024-11-15","current":-1.866798,"twenty":-11.826919,"median":-2.927982,"eighty":-0.684226,"marketCap":73860442},{"date":"2024-11-22","current":-1.780462,"twenty":-11.826919,"median":-2.927982,"eighty":-0.711322,"marketCap":70443968},{"date":"2024-11-29","current":-1.998621,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":79075443},{"date":"2024-12-06","current":-1.826205,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":72253794},{"date":"2024-12-13","current":-1.745275,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":69051795},{"date":"2024-12-20","current":-1.583415,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":62647798},{"date":"2024-12-27","current":-1.829724,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":72393011},{"date":"2025-01-03","current":-2.332897,"twenty":-11.826919,"median":-2.927982,"eighty":-0.721012,"marketCap":92301089},{"date":"2025-01-10","current":-2.132332,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":84365701},{"date":"2025-01-17","current":-2.05492,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":81302920},{"date":"2025-01-24","current":-2.090107,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":82695094},{"date":"2025-01-31","current":-2.068995,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":81859790},{"date":"2025-02-07","current":-2.019733,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":79910747},{"date":"2025-02-14","current":-1.738893,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":82256942},{"date":"2025-02-21","current":-1.751103,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":82834183},{"date":"2025-02-28","current":-1.549757,"twenty":-11.839382,"median":-2.927982,"eighty":-0.720352,"marketCap":73309695},{"date":"2025-03-07","current":-1.629075,"twenty":-11.851844,"median":-2.928824,"eighty":-0.719421,"marketCap":77061766},{"date":"2025-03-14","current":-1.659582,"twenty":-11.851844,"median":-2.928824,"eighty":-0.719421,"marketCap":78504871},{"date":"2025-03-21","current":-1.690089,"twenty":-11.851844,"median":-2.928824,"eighty":-0.732399,"marketCap":79947975},{"date":"2025-03-28","current":-1.604669,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":75907283},{"date":"2025-04-04","current":-1.39112,"twenty":-11.851844,"median":-2.928824,"eighty":-0.738355,"marketCap":65805553},{"date":"2025-04-11","current":-1.250788,"twenty":-11.839382,"median":-2.927982,"eighty":-0.739388,"marketCap":59167274},{"date":"2025-04-17","current":-1.262991,"twenty":-11.839382,"median":-2.927982,"eighty":-0.739388,"marketCap":59744515}],"updateTime":1745007306134}}}